Results 21 to 30 of about 305,984 (384)

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies

European Heart Journal, Supplement, 2023
Late gadolinium enhancement (LGE) is the most relevant tool of cardiac magnetic resonance for tissue characterization, and it plays a pivotal role for diagnostic and prognostic assessment of cardiomyopathies.
G. Aquaro, Carmelo De Gori, L. Faggioni, M. L. Parisella, D. Cioni, R. Lencioni, E. Neri   +6 more
semanticscholar   +1 more source

From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies

Europace, 2023
In the early nineties, few years before the birth of Europace, the clinical and scientific world of familial arrhythmogenic conditions was revolutionized by the identification of the first disease-causing genes. The explosion of genetic studies over a 15-
L. Crotti, P. Brugada, H. Calkins, P. Chevalier, G. Conte, G. Finocchiaro, P. Postema, V. Probst, P. Schwartz, E. Behr   +9 more
semanticscholar   +1 more source

Non Coding RNAs as Regulators of Wnt/β-Catenin and Hippo Pathways in Arrhythmogenic Cardiomyopathy

Biomedicines, 2022
Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy histologically characterized by the replacement of myocardium by fibrofatty infiltration, cardiomyocyte loss, and inflammation.
Marina Piquer-Gil, Sofía Domenech-Dauder, Marta Sepúlveda-Gómez, Carla Machí-Camacho, Aitana Braza-Boïls, Esther Zorio   +5 more
doaj   +1 more source

Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies

Science, 2022
Pathogenic variants in genes that cause dilated cardiomyopathy (DCM) and arrhythmogenic cardiomyopathy (ACM) convey high risks for the development of heart failure through unknown mechanisms.
D. Reichart, E. Lindberg, H. Maatz, Antonio M A Miranda, A. Viveiros, Nikolay Shvetsov, Anna Gärtner, Emily R. Nadelmann, Michael Lee, Kazumasa Kanemaru, Jorge Ruiz-Orera, V. Strohmenger, D. DeLaughter, Giannino Patone, Hao Zhang, A. Woehler, C. Lippert, Yuri Kim, E. Adami, J. Gorham, Sam N. Barnett, Kemar J Brown, R. Buchan, R. Chowdhury, C. Constantinou, J. Cranley, L. Felkin, H. Fox, Ahla Ghauri, J. Gummert, M. Kanda, Ruoyan Li, L. Mach, B. McDonough, Sara Samari, Farnoush Shahriaran, C. Yapp, C. Stanasiuk, P. Theotokis, F. Theis, Antoon J. van den Bogaerdt, H. Wakimoto, J. Ware, Catherine L. Worth, P. Barton, Young‐Ae Lee, S. Teichmann, H. Milting, M. Noseda, G. Oudit, M. Heinig, J. Seidman, N. Hubner, C. Seidman   +53 more
semanticscholar   +1 more source

State-of-the-Art Imaging of Infiltrative Cardiomyopathies: A Scientific Statement From the American Heart Association.

Circulation Cardiovascular Imaging, 2023
Infiltrative cardiomyopathies comprise a broad spectrum of inherited or acquired conditions caused by deposition of abnormal substances within the myocardium.
Anupama Kottam, Kate Hanneman, Aldo L Schenone, M. Daubert, Gursukhman Deep Sidhu, R. Gropler, Mario J. Garcia   +6 more
semanticscholar   +1 more source

Re-Definition of the Epidemiology of Cardiac Amyloidosis

Biomedicines, 2022
The epidemiology of cardiac amyloidosis (CA), traditionally considered a rare and incurable disease, has changed drastically over the last ten years, particularly due to the advances in diagnostic methods and therapeutic options in the field of ...
Maddalena Rossi, Guerino Giuseppe Varrà, Aldostefano Porcari, Riccardo Saro, Linda Pagura, Andrea Lalario, Franca Dore, Rossana Bussani, Gianfranco Sinagra, Marco Merlo   +9 more
doaj   +1 more source

Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination

Frontiers in Cardiovascular Medicine, 2021
Background: The prevalence of cardiac amyloidosis (CA) is unknown.Aims and Methods: We sought to (a) determine the prevalence of CA in unselected patients ≥75 years undergoing autopsy, (b) characterize cardiological profiles of CA and non-CA patients by ...
Aldostefano Porcari, Rossana Bussani, Marco Merlo, Guerino Giuseppe Varrà, Linda Pagura, Davide Rozze, Gianfranco Sinagra   +6 more
doaj   +1 more source

The pivotal role of ECG in cardiomyopathies

Frontiers in Cardiovascular Medicine, 2023
Cardiomyopathies are a heterogeneous group of pathologies characterized by structural and functional alterations of the heart. Recent technological advances in cardiovascular imaging offer an opportunity for deep phenotypic and etiological definition ...
Elisa Silvetti, O. Lanza, F. Romeo, A. Martino, E. Fedele, C. Lanzillo, C. Crescenzi, Francesca Fanisio, L. Calò   +8 more
semanticscholar   +1 more source

Cardiomyopathies

Autoimmunity, 2004
Cardiomyopathies include a wide variety of cardiac diseases. The value of MR imaging is not only to provide information about cardiac function, but also to detect the underlying cause of the disease.
Noel R, Rose, Daniela, Cihakova
openaire   +4 more sources

Clinical Characteristics for the Improvement of Cushing's Syndrome Complicated With Cardiomyopathy After Treatment With a Literature Review

Frontiers in Cardiovascular Medicine, 2021
Background: Endogenous Cushing's syndrome (CS), also called hypercortisolism, leads to a significant increase in mortality due to excessive cortisol production, which is mainly due to cardiovascular disease. CS complicated with cardiomyopathies, which is
Sisi Miao, Sisi Miao, Lin Lu, Ling Li, Yining Wang, Zhaolin Lu, Huijuan Zhu, Linjie Wang, Lian Duan, Xiaoping Xing, Yong Yao, Ming Feng, Renzhi Wang   +12 more
doaj   +1 more source